This company listing is no longer active
RJF.D Stock Overview
A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Laboratorio Reig Jofre, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.032 |
| 52 Week High | €0.049 |
| 52 Week Low | €0.032 |
| Beta | 0.89 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -10.25% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| RJF.D | ES Pharmaceuticals | ES Market | |
|---|---|---|---|
| 7D | -10.0% | 2.3% | 0.2% |
| 1Y | n/a | 25.1% | 16.0% |
Return vs Industry: Insufficient data to determine how RJF.D performed against the Spanish Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how RJF.D performed against the Spanish Market.
Price Volatility
| RJF.D volatility | |
|---|---|
| RJF.D Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 3.1% |
| 10% most volatile stocks in ES Market | 6.3% |
| 10% least volatile stocks in ES Market | 0.9% |
Stable Share Price: RJF.D has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RJF.D's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1929 | 1,196 | Ignasi Biosca Reig | www.reigjofre.com |
Laboratorio Reig Jofre, S.A., a pharmaceutical company, researches, develops, manufactures, and markets pharmaceutical products and food supplements. The company offers prescription medicines, OTCs, medical devices, and cosmetics. Its products include pharmaceutical technologies products, such as antibiotics, and injectable and other products; specialty pharmacare products, which include skin, hair, and nail health, joint health and pain, women’s health, respiratory/ENT, and pediatrics; and consumer healthcare products under the Forté Pharma brand.
Laboratorio Reig Jofre, S.A. Fundamentals Summary
| RJF.D fundamental statistics | |
|---|---|
| Market cap | €217.94m |
| Earnings (TTM) | €5.09m |
| Revenue (TTM) | €239.87m |
42.8x
P/E Ratio0.9x
P/S RatioIs RJF.D overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RJF.D income statement (TTM) | |
|---|---|
| Revenue | €239.87m |
| Cost of Revenue | €96.90m |
| Gross Profit | €142.97m |
| Other Expenses | €137.88m |
| Earnings | €5.09m |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Jul 26, 2022
| Earnings per share (EPS) | 0.066 |
| Gross Margin | 59.60% |
| Net Profit Margin | 2.12% |
| Debt/Equity Ratio | 25.1% |
How did RJF.D perform over the long term?
See historical performance and comparison